1. Home
  2. TREE vs PRTA Comparison

TREE vs PRTA Comparison

Compare TREE & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$41.72

Market Cap

587.3M

Sector

Finance

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.26

Market Cap

501.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
PRTA
Founded
1996
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
587.3M
501.2M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
TREE
PRTA
Price
$41.72
$9.26
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$71.25
$19.00
AVG Volume (30 Days)
377.6K
483.6K
Earning Date
03-02-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
10.78
N/A
Revenue
$1,117,324,000.00
$814,000.00
Revenue This Year
$19.03
$1,111.38
Revenue Next Year
$6.92
N/A
P/E Ratio
$4.03
N/A
Revenue Growth
24.12
N/A
52 Week Low
$32.65
$4.32
52 Week High
$77.35
$12.71

Technical Indicators

Market Signals
Indicator
TREE
PRTA
Relative Strength Index (RSI) 46.36 50.85
Support Level $39.04 $9.07
Resistance Level $50.94 $9.59
Average True Range (ATR) 1.83 0.39
MACD 0.48 0.02
Stochastic Oscillator 46.34 44.22

Price Performance

Historical Comparison
TREE
PRTA

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: